Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20221124002
TCTR20221124002
Completed
Phase 4

Efficacy of nalbuphine as an adjuvant to levobupivacaine scalp nerve block on intraoperative hemodynamic response and postoperative analgesia in elective supratentorial craniotomy

Department of anesthesiology, King chulalongkorn Memorial hospital0 sites60 target enrollmentNovember 24, 2022
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsScalp nerve block, Supratentorial craniotomy, Hemodynamic response, Postoperative analgesia, Levobupivacaine, Nalbuphine

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Scalp nerve block, Supratentorial craniotomy, Hemodynamic response, Postoperative analgesia, Levobupivacaine, Nalbuphine
Sponsor
Department of anesthesiology, King chulalongkorn Memorial hospital
Enrollment
60
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 24, 2022
End Date
June 1, 2022
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of anesthesiology, King chulalongkorn Memorial hospital

Eligibility Criteria

Inclusion Criteria

  • •Age 20 to 65 year\-olds
  • •ASA Physical Status I and II
  • •Undergoing elective supratentorial craniotomy for the first time

Exclusion Criteria

  • •Allergic to levobupivacaine, nalbuphine
  • •Infection at the block site/ Scalp Infection
  • •Preoperative Glasgow Coma Scale (GCS) \< 15
  • •Inability to measure pain intensity by verbal numeric rating scale (NRS)
  • •Inability to use PCA

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Comparison of nalbuphine with both levobupivacaine heavy 0.5% versus ropivacaine heavy 0.75% intrathecally for surgeries under spinal anaesthesia
CTRI/2023/02/049589Mahatma Gandhi medical college and hospital
Recruiting
Phase 4
albuphine as an addition to Bupivacaine in Supraclavicular block for Upper Limb Orthopedic Surgeries.Health Condition 1: null- patients posted for upper limb orthopaedic surgery of 18 to 60 yrs of age belonging to ASA I and II
CTRI/2017/07/009057Department of Anaesthesiology And Sir Takhatsinhji Hospital100
Not yet recruiting
Phase 4
se of nalbuphine drug as an additive with 0.5 percent levobupivacaine for upper limb orthopedic surgery in ultrasound guided supraclavicular block.Health Condition 1: O- Medical and Surgical
CTRI/2023/07/055741School of Medical Science And Research And Sharda Hospital, Greater Noida
Not yet recruiting
Not Applicable
A study to evaluate of nalbuphine 5mg used as an adjuvant with or without 0.5% levobupivacaine for postoperative relief of pain in lower limb surgeries in epidural anaesthesia.
CTRI/2022/05/042907JLN medical college Ajmer
Completed
Not Applicable
To study the effect of drug nalbuphine in nerve block in prologing the duration of pain relief
CTRI/2022/11/047436ESIC medical college90